Tobam Increases Holdings in Cardinal Health, Inc. $CAH

Tobam raised its stake in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 667.6% in the 4th quarter, Holdings Channel reports. The institutional investor owned 12,712 shares of the company’s stock after buying an additional 11,056 shares during the period. Tobam’s holdings in Cardinal Health were worth $2,612,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of the stock. Integrated Wealth Concepts LLC boosted its holdings in Cardinal Health by 6.9% in the 1st quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company’s stock valued at $601,000 after purchasing an additional 280 shares during the last quarter. Jones Financial Companies Lllp raised its position in shares of Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after buying an additional 14,034 shares during the period. Arrowstreet Capital Limited Partnership purchased a new position in Cardinal Health in the second quarter worth approximately $1,935,000. Cerity Partners LLC increased its stake in Cardinal Health by 17.0% during the second quarter. Cerity Partners LLC now owns 40,426 shares of the company’s stock worth $6,792,000 after acquiring an additional 5,880 shares during the last quarter. Finally, Nebula Research & Development LLC raised its position in Cardinal Health by 34.4% in the second quarter. Nebula Research & Development LLC now owns 10,334 shares of the company’s stock valued at $1,736,000 after purchasing an additional 2,646 shares during the period. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Get Cardinal Health alerts:

Cardinal Health Price Performance

CAH stock opened at $222.08 on Friday. The firm has a market capitalization of $52.01 billion, a P/E ratio of 33.96, a P/E/G ratio of 1.21 and a beta of 0.52. The business’s 50-day moving average is $204.34 and its two-hundred day moving average is $209.27. Cardinal Health, Inc. has a 1 year low of $137.75 and a 1 year high of $233.60.

Cardinal Health (NYSE:CAH – Get Free Report) last announced its quarterly earnings data on Thursday, April 30th. The company reported $3.17 EPS for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The business had revenue of $60.94 billion during the quarter, compared to the consensus estimate of $62.10 billion. During the same period in the previous year, the company posted $2.35 earnings per share. The business’s revenue for the quarter was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, analysts expect that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be paid a $0.5158 dividend. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Wednesday, July 1st. Cardinal Health’s payout ratio is presently 31.19%.

Wall Street Analyst Weigh In

CAH has been the subject of a number of recent analyst reports. Wells Fargo & Company cut their price objective on Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Zacks Research downgraded shares of Cardinal Health from a “strong-buy” rating to a “hold” rating in a research note on Friday, June 12th. Weiss Ratings cut shares of Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research report on Tuesday, May 19th. Robert W. Baird set a $248.00 target price on Cardinal Health in a research report on Friday, May 1st. Finally, Wall Street Zen lowered Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Monday, June 15th. Fourteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $246.93.

View Our Latest Stock Analysis on Cardinal Health

About Cardinal Health

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Read More

• Five stocks we like better than Cardinal Health
• Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself?
• Rackspace’s AI Land Grab: Plugging Into the Next Compute Boom
• Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore
• Why Kroger’s Pullback Could Be a Gift for Patient Investors

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.